Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1a Randomized, Double-blind, Placebo-controlled, Single Site, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Nezavist in Healthy Adults

NCT06633562 is registered in ClinicalTrials.gov with Lohocla Research Corporation as lead sponsor.

NCT NCT06633562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06633562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1a Randomized, Double-blind, Placebo-controlled, Single Site, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Nezavist in Healthy Adults
Lead sponsor
Lohocla Research Corporation
Phase
Phase 1
Overall status
Terminated
Start date
February 28, 2025
Completion date
December 22, 2025
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, safety evaluation of escalating doses, tolerability